Author: Steffen E. Eikenberry; Marina Mancuso; Enahoro Iboi; Tin Phan; Keenan Eikenberry; Yang Kuang; Eric Kostelich; Abba B. Gumel
Title: To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic Document date: 2020_4_11
ID: 28utunid_36
Snippet: Note that the product ϵ × π predicts quite well the effect of mask deployment: Figure 1 also shows (relative) peak hospitalizations and cumulative deaths as functions of this product. There is, however, a slight asymmetry between coverage and efficacy, such that increasing coverage of moderately effective masks is generally more useful than increasing the effectiveness of masks from a starting point of moderate coverage. Figure 2 : Equivalent .....
Document: Note that the product ϵ × π predicts quite well the effect of mask deployment: Figure 1 also shows (relative) peak hospitalizations and cumulative deaths as functions of this product. There is, however, a slight asymmetry between coverage and efficacy, such that increasing coverage of moderately effective masks is generally more useful than increasing the effectiveness of masks from a starting point of moderate coverage. Figure 2 : Equivalent β 0 ,β 0 (infectious contact rate) under baseline model dynamics as a function of mask coverage × efficacy, with the left panel giving the absolute value, and the right giving the ratio ofβ 0 to the true β 0 in the simulation with masks. That is, simulated epidemics are run with mask coverage and effectiveness ranging from 0 to 1, and the outcomes are tracked as synthetic data. The baseline model without mask dynamics is then fit to this synthetic data, with β 0 the trainable parameter; the resulting β 0 is theβ 0 . This is done for simulated epidemics with a true β 0 of 1.5, 1, or 0.5 day −1 .
Search related documents:
Co phrase search for related documents- baseline model and cumulative death: 1, 2, 3
- baseline model and efficacy coverage: 1, 2
- baseline model and mask coverage: 1, 2
- baseline model and mask coverage efficacy: 1, 2
- baseline model and mask coverage efficacy function: 1
- contact rate and efficacy coverage: 1, 2
- contact rate and infectious contact rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- contact rate and left panel: 1, 2, 3
- contact rate and mask coverage: 1
- contact rate and mask coverage efficacy: 1
- cumulative death and effectiveness mask coverage: 1, 2, 3
- cumulative death and mask coverage: 1, 2, 3
- effectiveness mask coverage and mask coverage: 1, 2, 3, 4, 5, 6
- efficacy coverage and increase coverage: 1, 2, 3, 4
- efficacy coverage and infectious contact rate: 1
- efficacy coverage and mask coverage: 1, 2, 3, 4, 5, 6, 7
- efficacy coverage and mask coverage efficacy: 1, 2, 3, 4, 5, 6, 7
- efficacy coverage and mask coverage efficacy function: 1
- increase coverage and mask coverage: 1
Co phrase search for related documents, hyperlinks ordered by date